Private-public alliance for the common good

Merck gets funding from GAVI to produce Ebola vaccine

Published in Microbiology

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

A private-public deal will fund Merck&Co to produce, stockpile and attain approval for an Ebola vaccine that showed promising results last year, Nature and Science report. GAVI, a swiss organization that helps poor countries vaccinate children, announced yesterday at the World Economic Forum in Davos, Switzerland, that it will provide US $5 million to make this possible.

This vaccine is currently being used to vaccinate all known contacts of the recent Sierra Leone Ebola victim.